Related Experiment Videos

Cytophotometric determination of DNA in mesotheliomas and reactive mesothelial cells

M A Hafiz1, R L Becker, U V Mikel

  • 1Department of Pathology, University of Maryland School of Medicine, Baltimore.

Insights

DNA analysis using Feulgen stain and cytophotometry can distinguish malignant mesothelioma from benign reactive mesothelial cells in effusions. This method offers valuable criteria for accurate diagnosis.

Area of Science:

  • Oncology
  • Cytopathology
  • Biomedical Imaging

Background:

  • Distinguishing malignant mesothelioma from reactive mesothelial proliferations in effusions is diagnostically challenging.
  • Accurate differentiation is crucial for appropriate patient management and treatment.

Purpose of the Study:

  • To evaluate the utility of nuclear DNA content analysis via cytophotometry in differentiating mesothelioma from reactive mesothelial cells.
  • To establish quantitative criteria for improved diagnostic accuracy in effusion cytology.

Main Methods:

  • Feulgen staining of effusion specimens from patients with mesothelioma and reactive mesothelial proliferations.
  • Quantitative DNA content analysis using cytophotometry.
  • Statistical analysis including discriminant modeling to identify differentiating parameters.

Main Results:

  • Mesothelioma cells exhibited significantly higher mean DNA content (MDNA) compared to reactive mesothelial cells (P < .001).
  • Other DNA-related parameters, including DNA/lymphocyte ratio and percentage of cells with high DNA content, also differed significantly.
  • A discriminant model correctly classified 100% of reactive effusions and 89% of mesothelioma effusions.

Conclusions:

  • Nuclear DNA content analysis by Feulgen cytophotometry provides reliable criteria for distinguishing mesothelioma from reactive mesothelial proliferations.
  • This quantitative method, when combined with traditional parameters, enhances diagnostic accuracy in effusion cytology.
  • DNA ploidy analysis offers a valuable adjunct for the definitive diagnosis of mesothelioma.

Related Concept Videos